Real World Evidence Study Showed use of Prolia Reduced Fracture Risk in Postmenopausal Women With Osteoporosis Versus Alendronate Treatment Longer Duration of Treatment With Prolia Was Associated...

Groundbreaking research conducted by a team of leading researchers at Entrinsic Bioscience (EBS) and the University of Florida revealed significant findings that will change the way we understand...

Graphic Packaging Holding Company (NYSE: GPK), a leading fiber-based consumer packaging company, announced today that Michael P. Doss, President and Chief Executive Officer, will present at the...

Hesai Technology (HSAI), a global leader in 3D lidar solutions, is set to attend the Xponential 2023 Expo from May 8th to 11th. At booth 4513, the team will showcase three sensors specifically...

Valo Health, Inc. ("Valo"), the technology company focused on transforming the drug discovery and development process using human-centric data and artificial intelligence, today announced its...

interCaribbean Airways is pleased to announce its platinum sponsorship of, and participation at the 41st edition of the Caribbean Hotel and Tourism Association's (CHTA) Caribbean Travel...

Biosion USA, Inc. (Biosion), a global R&D biotechnology company, today announced the upcoming presentation of discovery and development data for BSI-038, an anti-CD40 agonistic antibody at the...

Presentations to Highlight Company's Gene Therapies for Cancer and Diabetes AUSTIN, Texas, May 8, 2023 /PRNewswire/ -- Genprex, Inc. ("Genprex" or the "Company") (NASDAQ: GNPX), a clinical-stage...

REGENXBIO Inc. (Nasdaq: RGNX) today announced it will participate in the following upcoming investor conferences: BofA Securities 2023 Health Care Conference Fireside Chat Date: Wednesday, May 10,...

Vibrant Gastro, a medical technology company that developed an FDA-cleared drug-free treatment for chronic idiopathic constipation (CIC) in adults, presented an abstract at the 2023 Digestive...